The South African Health Product Regulatory Authority (SAHPRA) Complementary Medicines’ (CMs’) Hybrid Workshop successfully took place, offering attendees the option to participate either in person or via a virtual platform.
Key areas discussed during the workshop included:
SAHPRA responded to the 21 questions regarding Complementary Medicines (CMs).
The South African Pharmacy Council’s presentation on GPP Compliance and Inspections.
Insights from the National Department of Health regarding Pharmacy Premises Licences, as outlined in Section 22 of the Pharmacy Act 53 of 1974.
The National Consumer Commission’s role is to safeguard the public through oversight of non-medicinal “Grey Area Products.”
Industry representatives’ responses to SAHPRA’s feedback on the questions raised.
The workshop provided a valuable platform for dialogue between regulators and stakeholders
